Benefit of adjuvant mesenchymal stem cell transplantation to critical-sized peripheral nerve defect repair

• Verfasst von: Aman, Martin [VerfasserIn]
• Verfasst von: Schulte, Matthias [VerfasserIn]
• Verfasst von: Li, Yu [VerfasserIn]
• Verfasst von: Thomas, Benjamin [VerfasserIn]
• Verfasst von: Däschler, Simeon C. [VerfasserIn]
• Verfasst von: Mayrhofer-Schmid, Maximilian [VerfasserIn]
• Verfasst von: Kneser, Ulrich [VerfasserIn]
• Verfasst von: Harhaus-Wähner, Leila [VerfasserIn]
• Verfasst von: Böcker, Arne Hendrik [VerfasserIn]
• Titel: Benefit of adjuvant mesenchymal stem cell transplantation to critical-sized peripheral nerve defect repair
• Titelzusatz: a systematic review and meta-analysis of preclinical studies
• Verf.angabe: Martin Aman, Matthias Schulte, Yu Li, Benjamin Thomas, Simeon Daeschler, Maximilian Mayrhofer-Schmid, Ulrich Kneser, Leila Harhaus and Arne Boecker
• E-Jahr: 2023
• Jahr: 7 February 2023
• Umfang: 13 S.
• Fussnoten: Gesehen am 26.04.2023
• Titel Quelle: Enthalten in: Journal of Clinical Medicine
• Ort Quelle: Basel : MDPI, 2012
• Jahr Quelle: 2023
• Band/Heft Quelle: 12(2023), 4, Artikel-ID 1306, Seite 1-13
• ISSN Quelle: 2077-0383
• DOI: doi:10.3390/jcm12041306
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: MSC
• Sach-SW: nerve injury
• Sach-SW: nerve reconstruction
• Sach-SW: peripheral nerve
• Sach-SW: stem cell
• Sach-SW: trauma
• K10plus-PPN: 184360678X

Abstract

Critically sized nerve defects cause devastating life-long disabilities and require interposition for reconstruction. Additional local application of mesenchymal stem cells (MSCs) is considered promising to enhance peripheral nerve regeneration. To better understand the role of MSCs in peripheral nerve reconstruction, we performed a systematic review and meta-analysis of the effects of MSCs on critically sized segment nerve defects in preclinical studies. 5146 articles were screened following PRISMA guidelines using PubMed and Web of Science. A total of 27 preclinical studies (n = 722 rats) were included in the meta-analysis. The mean difference or the standardized mean difference with 95% confidence intervals for motor function, conduction velocity, and histomorphological parameters of nerve regeneration, as well as the degree of muscle atrophy, was compared in rats with critically sized defects and autologous nerve reconstruction treated with or without MSCs. The co-transplantation of MSCs increased the sciatic functional index (3.93, 95% CI 2.62 to 5.24, p < 0.00001) and nerve conduction velocity recovery (1.49, 95% CI 1.13 to 1.84, p = 0.009), decreased the atrophy of targeted muscles (gastrocnemius: 0.63, 95% CI 0.29 to 0.97 p = 0.004; triceps surae: 0.08, 95% CI 0.06 to 0.10 p = 0.71), and promoted the regeneration of injured axons (axon number: 1.10, 95% CI 0.78 to 1.42, p < 0.00001; myelin sheath thickness: 0.15, 95% CI 0.12 to 0.17, p = 0.28). Reconstruction of critically sized peripheral nerve defects is often hindered by impaired postoperative regeneration, especially in defects that require an autologous nerve graft. This meta-analysis indicates that additional application of MSC can enhance postoperative peripheral nerve regeneration in rats. Based on the promising results in vivo experiments, further studies are needed to demonstrate potential clinical benefits.